Observational studyPloS one2020

High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study.

Vennie Mbaziira Nabitaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.